Cumulative Yield from Patient Surveillance Cultures for Methicillin-Resistant Staphylococcus aureus during a Hospital Outbreak

Infection Control and Hospital Epidemiology

Volumn 18, Issue 11, 1997, Pages 776-778

  Forward, Kevin R ^a   Arbique, Judy C ^b  

^a QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANADA; COST BENEFIT ANALYSIS; CROSS INFECTION; DRUG EFFECT; ECONOMICS; EPIDEMIC; HOSPITAL COST; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGY; MULTIHOSPITAL SYSTEM; PENICILLIN RESISTANCE; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

COST-BENEFIT ANALYSIS; CROSS INFECTION; DISEASE OUTBREAKS; HOSPITAL COSTS; HUMANS; METHICILLIN RESISTANCE; MULTI-INSTITUTIONAL SYSTEMS; NOVA SCOTIA; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 0031261549     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.2307/30141325     Document Type: Article

References (10)

1. Simor AE, Payton S, Ofner M, Johnson W, Smith J. Surveillance for methicillin-resistant Staphylococcus aureus (MRSA) in Canadian hospitals. Abstracts of the Sixth Annual Meeting of the Society for Healthcare Epidemiology of America; Washington, DC; April 1996. Abstract 77.
2. Jernigan JA, Clemence MA, Stott GA, et al. Control of methicillin-resistant Staphylococcus aureus at a university hospital; one decade later. Infect Control Hosp Epidemiol 1995;16:686-696.
3. Rao N, Jacobs S, Joyce L. Cost-effective eradication of an outbreak of methicillin-resistant Staphylococcus aureus in a community teaching hospital. Infect Control Hosp Epidemiol 1988;6:255-260.
4. Craven DE, Reed C, Kollisch N, et al. A large outbreak of infections caused by a strain of Staphylococcus aureus resistant to oxacillin and aminoglycosides. Am J Med 1981;71:53-58.
5. Bitar CM, Mayhall CG, Lamb VA, Bradshaw TJ, Spadora AC, Dalton HK. Outbreak due to methicillin- and rifampin-resistant Staphylococcus aureus: epidemiology and eradication of the resistant strain from the hospital. Infect Control 1987;8:15-23.
6. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A3. Villanova, PA: National Committee for Clinical Laboratory Standards; 1993.
7. Murakami K, Minamide W, Wda K, Nakamura E, Teroaka H, Watanabe S. Identification of methicillin-resistant strains of staphylococci by polymerase chain reaction. J Clin Microbiol 1991;29:2240-2244.
8. Jansen MA, Webster JA, Straus N. Rapid identification of bacteria on the basis of polymerase chain reaction-amplified ribosomal DNA spacer polymorphisms. Appl Environ Microbiol 1993;59:945-952.
9. Wakefield DS, Helms CM, Massanare RM, Mori M, Pfaller M. Cost of nosocomial infection: relative contribution of laboratory, antibiotic, and per diem costs in serious Staphylococcus aureus infections. Am J Infect Control 1988;16:185-192.
10. Rimland D, Roberson B. Gastrointestinal carriage of methicillin-resistant Staphylococcus aureus. J Clin Microbiol 1986;24:137-138.